In November 1996, the FDA approved donepezil for prescription use in treating mild to moderate Alzheimer's disease.

Since then, many patients have been prescribed this newly approved medication. The published results of double-blind studies have indicated statistically significant improvements in scores on such neuropsychological tests as the ADAS-Cog., the MMSE, and the Clinician's Interview-Based Impression of Change (CIBIC). These results were the basis for FDA approval of donepezil.

 

Why is this medication prescribed?

Other uses for this medicine

Dosage and using this medicine

What special precautions should I follow?

What should I do if I forget a dose?

What side effects can this medication cause?

What storage conditions are needed for this medicine?

In case of an emergency/overdose